Back to Market Feed

Product Information

DISOPYRAMIDE 150 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.5006 per EA under NDC 75907002601. Its NADAC has been published 96 times since Oct 23, 2024.

FDA first approved this application on May 31, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DISOPYRAMIDE 150 MG CAPSULE

DISOPYRAMIDE PHOSPHATE
$1.5006per EA

Strength

150 mg/1

NDC

75907002601

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DISOPYRAMIDE PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA070173

FDA Approved

5/31/1985

TE Code

AB

On Market Since

3/15/2024

Pharmacological Classes

Antiarrhythmic

Price Statistics

The NADAC for DISOPYRAMIDE 150 MG CAPSULE has been published 96 times since Oct 23, 2024, and over the history we have for it it has risen 8.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5006 per EA
All-time high$1.7091 (Mar 11, 2026)
All-time low$1.0595 (Jan 22, 2025)
52-week high$1.7091
52-week low$1.4907
Median price$1.5318
Average price$1.4473
Largest weekly change-22.9% (Nov 20, 2024)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

-2.3%

1M

-2.3%

3M

-7.3%

6M

-12.2%

1Y

-10.0%

3Y

N/A

5Y

N/A

All

+8.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DISOPYRAMIDE PHOSPHATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0280
per GM
GNP LIDOCAINE HCL 4% CREAM
Generic
46122061410•AmerisourceBergen
$0.0517
per GM
LIDOCAINE HCL 4% CREAM
Generic
70000009801•Cardinal Health
$0.0517
per GM
LIDOCAINE HCL 1% VIAL
Generic
00409427602•Hospira Inc.
$0.0542
per ML
LIDOCAINE HCL 2% VIAL
Generic
00409427702•Hospira Inc.
$0.0569
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016300•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016330•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% VIAL
Generic
00143957710•Hikma Pharmaceuticals USA Inc.
$0.0694
per ML
LIDOCAINE HCL 1% VIAL
Generic
00409427601•Hospira Inc.
$0.0694
per ML

Frequently asked questions

What is the NADAC price of DISOPYRAMIDE 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 150 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $1.5006 per EA (NDC 75907002601), effective Aug 19, 2026.

How has the price of DISOPYRAMIDE 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has risen 8.8%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 150 MG CAPSULE?

Since Oct 23, 2024, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has ranged from a low of $1.0595 (Jan 22, 2025) to a high of $1.7091 (Mar 11, 2026), with a median of $1.5318 per EA.

Are there cheaper alternatives to DISOPYRAMIDE 150 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DISOPYRAMIDE 150 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DISOPYRAMIDE 150 MG CAPSULE?

DISOPYRAMIDE 150 MG CAPSULE (NDC 75907002601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.